Atyr Pharma Stock Price History
| LIFE Stock | USD 1.62 0.02 1.22% |
Below is the normalized historical share price chart for aTyr Pharma extending back to May 07, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ATyr Pharma stands at 1.62, as last reported on the 24th of April, with the highest price reaching 1.70 and the lowest price hitting 1.61 during the day.
If you're considering investing in ATyr Stock, it is important to understand the factors that can impact its price. We consider ATyr Pharma moderately volatile. aTyr Pharma secures Sharpe Ratio (or Efficiency) of 0.0369, which signifies that the company had a 0.0369% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for aTyr Pharma, which you can use to evaluate the volatility of the firm. Please confirm ATyr Pharma's Downside Deviation of 3.46, semi deviation of 3.05, and Risk Adjusted Performance of 0.0504 to double-check if the risk estimate we provide is consistent with the expected return of 0.18%.
At present, ATyr Pharma's Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Sale Purchase Of Stock is expected to grow to about 110.2 K, whereas Common Stock Total Equity is forecasted to decline to 9,405. . At present, ATyr Pharma's Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price Sales Ratio is expected to grow to 224.83, whereas Price Book Value Ratio is forecasted to decline to 0.79. ATyr Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 7th of May 2015 | 200 Day MA 1.6266 | 50 Day MA 1.8309 | Beta 1.229 |
ATyr |
Sharpe Ratio = 0.0369
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | LIFE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.85 actual daily | 42 58% of assets are more volatile |
Expected Return
| 0.18 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 2 98% of assets perform better |
Based on monthly moving average ATyr Pharma is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ATyr Pharma by adding it to a well-diversified portfolio.
Price Book 1.304 | Enterprise Value Ebitda (0.67) | Price Sales 334.8923 | Shares Float 60.1 M | Wall Street Target Price 22.6 |
ATyr Pharma Stock Price History Chart
There are several ways to analyze ATyr Stock price data. The simplest method is using a basic ATyr candlestick price chart, which shows ATyr Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 16, 2024 | 2.02 |
| Lowest Price | January 26, 2024 | 1.58 |
ATyr Pharma April 24, 2024 Stock Price Synopsis
Various analyses of ATyr Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell ATyr Stock. It can be used to describe the percentage change in the price of ATyr Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of ATyr Stock.| ATyr Pharma Price Daily Balance Of Power | (0.22) | |
| ATyr Pharma Price Rate Of Daily Change | 0.99 | |
| ATyr Pharma Accumulation Distribution | 12,615 | |
| ATyr Pharma Price Action Indicator | (0.04) |
ATyr Pharma April 24, 2024 Stock Price Analysis
ATyr Stock Price History Data
The price series of ATyr Pharma for the period between Thu, Jan 25, 2024 and Wed, Apr 24, 2024 has a statistical range of 0.6 with a coefficient of variation of 9.38. The daily prices for the period are spread out with arithmetic mean of 1.78. The median price for the last 90 days is 1.79. The company underwent 1:14 stock split on 1st of July 2019. aTyr Pharma issued dividends to stockholders on 2019-07-01.| Open | High | Low | Close | Volume | ||
| 04/23/2024 | 1.68 | 1.70 | 1.61 | 1.62 | 238,288 | |
| 04/22/2024 | 1.60 | 1.69 | 1.58 | 1.64 | 293,599 | |
| 04/19/2024 | 1.65 | 1.65 | 1.58 | 1.60 | 159,073 | |
| 04/18/2024 | 1.60 | 1.64 | 1.58 | 1.62 | 276,007 | |
| 04/17/2024 | 1.64 | 1.64 | 1.58 | 1.59 | 537,232 | |
| 04/16/2024 | 1.70 | 1.70 | 1.60 | 1.61 | 359,600 | |
| 04/15/2024 | 1.74 | 1.74 | 1.65 | 1.70 | 307,558 | |
| 04/12/2024 | 1.74 | 1.78 | 1.70 | 1.74 | 252,546 | |
| 04/11/2024 | 1.77 | 1.79 | 1.72 | 1.76 | 232,532 | |
| 04/10/2024 | 1.70 | 1.78 | 1.69 | 1.77 | 452,151 | |
| 04/09/2024 | 1.87 | 1.87 | 1.69 | 1.72 | 790,480 | |
| 04/08/2024 | 1.88 | 1.90 | 1.82 | 1.83 | 241,352 | |
| 04/05/2024 | 1.88 | 1.89 | 1.82 | 1.86 | 241,624 | |
| 04/04/2024 | 1.87 | 1.94 | 1.82 | 1.87 | 459,589 | |
| 04/03/2024 | 1.84 | 1.86 | 1.76 | 1.85 | 319,462 | |
| 04/02/2024 | 1.89 | 1.90 | 1.81 | 1.84 | 375,012 | |
| 04/01/2024 | 1.97 | 1.99 | 1.89 | 1.91 | 293,199 | |
| 03/28/2024 | 2.04 | 2.05 | 1.89 | 1.95 | 726,105 | |
| 03/27/2024 | 1.92 | 2.09 | 1.92 | 2.00 | 1,200,945 | |
| 03/26/2024 | 1.91 | 1.94 | 1.85 | 1.92 | 282,116 | |
| 03/25/2024 | 1.93 | 1.98 | 1.87 | 1.92 | 337,242 | |
| 03/22/2024 | 1.97 | 2.03 | 1.94 | 1.95 | 355,219 | |
| 03/21/2024 | 2.00 | 2.03 | 1.85 | 2.02 | 891,085 | |
| 03/20/2024 | 2.01 | 2.15 | 1.95 | 2.02 | 904,451 | |
| 03/19/2024 | 2.01 | 2.05 | 1.91 | 2.00 | 399,401 | |
| 03/18/2024 | 2.03 | 2.03 | 1.90 | 1.96 | 867,623 | |
| 03/15/2024 | 1.62 | 2.01 | 1.62 | 1.99 | 1,442,698 | |
| 03/14/2024 | 1.62 | 1.64 | 1.55 | 1.62 | 483,981 | |
| 03/13/2024 | 1.62 | 1.68 | 1.61 | 1.63 | 301,208 | |
| 03/12/2024 | 1.59 | 1.63 | 1.57 | 1.62 | 427,520 | |
| 03/11/2024 | 1.57 | 1.66 | 1.57 | 1.60 | 472,008 | |
| 03/08/2024 | 1.67 | 1.72 | 1.58 | 1.59 | 751,465 | |
| 03/07/2024 | 1.72 | 1.73 | 1.64 | 1.66 | 1,282,132 | |
| 03/06/2024 | 1.69 | 1.72 | 1.67 | 1.70 | 611,048 | |
| 03/05/2024 | 1.77 | 1.79 | 1.63 | 1.67 | 1,082,353 | |
| 03/04/2024 | 1.90 | 1.91 | 1.72 | 1.79 | 958,347 | |
| 03/01/2024 | 1.94 | 1.95 | 1.89 | 1.91 | 304,765 | |
| 02/29/2024 | 1.90 | 2.00 | 1.90 | 1.92 | 295,349 | |
| 02/28/2024 | 2.00 | 2.03 | 1.85 | 1.90 | 1,184,885 | |
| 02/27/2024 | 2.01 | 2.08 | 1.98 | 2.00 | 822,006 | |
| 02/26/2024 | 1.89 | 1.95 | 1.85 | 1.94 | 304,732 | |
| 02/23/2024 | 1.87 | 1.92 | 1.85 | 1.91 | 495,735 | |
| 02/22/2024 | 2.02 | 2.04 | 1.86 | 1.89 | 1,125,588 | |
| 02/21/2024 | 1.91 | 2.01 | 1.84 | 1.97 | 730,397 | |
| 02/20/2024 | 2.05 | 2.12 | 1.81 | 1.88 | 1,714,068 | |
| 02/16/2024 | 1.92 | 2.08 | 1.88 | 2.02 | 557,070 | |
| 02/15/2024 | 1.90 | 1.96 | 1.88 | 1.93 | 253,389 | |
| 02/14/2024 | 1.91 | 1.95 | 1.86 | 1.92 | 587,401 | |
| 02/13/2024 | 1.97 | 1.99 | 1.75 | 1.91 | 830,027 | |
| 02/12/2024 | 1.93 | 2.03 | 1.93 | 1.97 | 833,826 | |
| 02/09/2024 | 2.00 | 2.05 | 1.93 | 1.97 | 593,622 | |
| 02/08/2024 | 1.65 | 2.02 | 1.65 | 1.97 | 1,521,941 | |
| 02/07/2024 | 1.66 | 1.70 | 1.63 | 1.66 | 137,405 | |
| 02/06/2024 | 1.72 | 1.72 | 1.65 | 1.65 | 187,870 | |
| 02/05/2024 | 1.75 | 1.79 | 1.66 | 1.70 | 741,054 | |
| 02/02/2024 | 1.60 | 1.77 | 1.48 | 1.76 | 547,190 | |
| 02/01/2024 | 1.59 | 1.62 | 1.58 | 1.60 | 160,434 | |
| 01/31/2024 | 1.57 | 1.63 | 1.57 | 1.60 | 185,812 | |
| 01/30/2024 | 1.61 | 1.63 | 1.58 | 1.61 | 142,392 | |
| 01/29/2024 | 1.58 | 1.63 | 1.55 | 1.62 | 239,876 | |
| 01/26/2024 | 1.55 | 1.58 | 1.54 | 1.58 | 116,821 |
About ATyr Pharma Stock history
ATyr Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ATyr is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in aTyr Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ATyr Pharma stock prices may prove useful in developing a viable investing in ATyr Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 53.6 M | 56.3 M | |
| Net Loss | -40.8 M | -38.8 M |
ATyr Pharma Quarterly Net Working Capital |
|
ATyr Pharma Stock Technical Analysis
ATyr Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
ATyr Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ATyr Pharma's price direction in advance. Along with the technical and fundamental analysis of ATyr Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ATyr to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0504 | |||
| Jensen Alpha | 0.2245 | |||
| Total Risk Alpha | (0.30) | |||
| Sortino Ratio | 0.0675 | |||
| Treynor Ratio | 0.282 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in aTyr Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. For information on how to trade ATyr Stock refer to our How to Trade ATyr Stock guide.Note that the aTyr Pharma information on this page should be used as a complementary analysis to other ATyr Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for ATyr Stock analysis
When running ATyr Pharma's price analysis, check to measure ATyr Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATyr Pharma is operating at the current time. Most of ATyr Pharma's value examination focuses on studying past and present price action to predict the probability of ATyr Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATyr Pharma's price. Additionally, you may evaluate how the addition of ATyr Pharma to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
Is ATyr Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATyr Pharma. If investors know ATyr will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATyr Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.94) | Revenue Per Share 0.007 | Quarterly Revenue Growth (1.00) | Return On Assets (0.32) | Return On Equity (0.62) |
The market value of aTyr Pharma is measured differently than its book value, which is the value of ATyr that is recorded on the company's balance sheet. Investors also form their own opinion of ATyr Pharma's value that differs from its market value or its book value, called intrinsic value, which is ATyr Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATyr Pharma's market value can be influenced by many factors that don't directly affect ATyr Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATyr Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ATyr Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATyr Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.